Decoy Therapeutics Inc. (DCOY)

NASDAQ: DCOY · Real-Time Price · USD

3.200

-0.080 (-2.44%)

At close: Aug 21, 2026, 4:00 PM EDT

3.260

+0.060 (1.87%)

After-hours: Aug 21, 2026, 7:48 PM EDT

Decoy Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.29	10.71	2.43	5.9	12.11	29.21
Cash & Short-Term Investments	8.29	10.71	2.43	5.9	12.11	29.21
Cash Growth	942.81%	339.92%	-58.74%	-51.27%	-58.56%	162.75%
Receivables	-	-	-	-	1.61	-
Prepaid Expenses	0.28	0.28	0.33	0.62	0.8	0.95
Other Current Assets	-	-	0.22	-	-	-
Total Current Assets	8.57	10.99	2.99	6.52	14.52	30.16
Property, Plant & Equipment	0.4	0.04	-	-	-	-
Goodwill	-	-	-	-	-	8.87
Long-Term Accounts Receivable	-	-	-	-	-	1.61
Other Long-Term Assets	0.03	0.03	0.04	0.07	0.13	0.19
Total Assets	9	11.06	3.02	6.59	14.65	40.83

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.33	0.94	0.94	0.6	2.86	1.54
Accrued Expenses	0.22	0.86	0.35	0.41	1.41	0.57
Short-Term Debt	-	-	0.22	0.29	-	-
Current Unearned Revenue	3	3.23	-	-	-	-
Other Current Liabilities	0.14	0.14	-	-	-	-
Total Current Liabilities	4.68	5.17	1.51	1.3	4.27	2.11
Total Liabilities	4.68	5.17	1.51	1.3	4.27	2.11

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	103.36	100.33	83.44	81.64	74.19	70.92
Retained Earnings	-99.04	-94.44	-81.92	-76.35	-63.81	-32.2
Total Common Equity	4.32	5.89	1.51	5.29	10.38	38.72
Shareholders' Equity	4.32	5.89	1.51	5.29	10.38	38.72
Total Liabilities & Equity	9	11.06	3.02	6.59	14.65	40.83

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	0.22	0.29	-	-
Net Cash (Debt)	8.29	10.71	2.21	5.61	12.11	29.21
Net Cash Growth	942.81%	384.03%	-60.56%	-53.66%	-58.56%	174.53%
Net Cash Per Share	23.17	110.45	27.59	-	-	-
Filing Date Shares Outstanding	0.66	0.53	-	-	-	0
Total Common Shares Outstanding	0.53	0.53	-	-	-	0
Working Capital	3.89	5.82	1.48	5.22	10.25	28.05
Book Value Per Share	8.12	11.07	-	-	-	30805.88
Tangible Book Value	4.32	5.89	1.51	5.29	10.38	29.86
Tangible Book Value Per Share	8.12	11.07	-	-	-	23752.65